Keyword Search
Legend:
CC = Vancouver Convention Centre F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: Real World Evidence returned 12 record(s)
|
|
Monday, 07/30/2018
|
The Role of Real World Evidence in a Regulatory Environment: Focus on Safety
Estelle Russek-Cohen, US FDA CDER
8:35 AM
|
Learning Individualized Treatment Rules from Electronic Health Records Data
Yuanjia Wang, Columbia University
9:00 AM
|
Linking Medicare Current Beneficiary Survey (MCBS) to Augment Post-Market Real World Data from Medicare Claims: a Multiple Imputation Approach
Yun Lu, FDA; Xiyuan Wu, Acumen LLC; Yoganand Chillarige, Acumen LLC; Michael Wernecke, Acumen LLC; Hector Izurieta, FDA; Jeffrey Kelman, CMS; Richard Forshee , FDA
9:20 AM
|
Visual Analytics in the Real World Evidence Data Realm
Melvin Munsaka, AbbVie, Inc.; Kefei Zhou, Theravance Biopharma; Krishan P. Singh, GlaxoSmithKline
9:35 AM
|
|
Thursday, 08/02/2018
|
Utilization of Historical Data and Real World Evidence in Clinical Trial Development - Case Studies in Rare Disease and Oncology
Florence H Yong, Pfizer Inc.; Ray Li, Pfizer Inc.; Steven Y Hua, Celgene - Receptos; Jeffery Palmer, Pfizer Inc.; Roberto Bugarini, Pfizer Inc.
8:50 AM
|
Deriving and Analyzing Endpoints from Electronic Health Record Data: a Case Study from Clinical Oncology
Sandra Griffith, Flatiron Health; Ariel Bourla, Flatiron Health; Bryan Bowser, Flatiron Health ; Geoff Calkins, Flatiron Health; Joe Chang, Flatiron Health; Rebecca Miksad , Flatiron Health ; Brian Segal, Flatiron Health; Elizabeth Sweeney, Flatiron Health ; Erin Williams, Flatiron Health ; Paul You , Flatiron Health ; Amy Abernethy, Flatiron Health
11:15 AM
|
|
|
